A Randomized, Double-Blind, Parallel, Vehicle-Controlled Phase III Trial to Assess the Efficacy and Safety of Topical SR-T100 Gel in the Treatment of Patients With Actinic Keratosis.

Trial Profile

A Randomized, Double-Blind, Parallel, Vehicle-Controlled Phase III Trial to Assess the Efficacy and Safety of Topical SR-T100 Gel in the Treatment of Patients With Actinic Keratosis.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Feb 2016

At a glance

  • Drugs SR T100 (Primary)
  • Indications Actinic keratosis; Porokeratosis
  • Focus Therapeutic Use
  • Sponsors G&E Herbal Biotechnology
  • Most Recent Events

    • 17 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Aug 2015 Planned End Date changed from 1 Jun 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov
    • 12 Aug 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top